A 49-year-old woman with a 20-year history of Sjögren's syndrome (SS) was incidentally found to have an abnormal chest X-ray along with dyspnea and desaturation. Chest CT findings showed multiple cystic shadows, ground glass opacity, and small nodule-like lymphocytic interstitial pneumonia (LIP), which have been previously reported. She was diagnosed by surgical lung biopsy to have mucosa-associated lymphoid tissue (MALT) lymphoma. It was difficult to detect the presence of lymphoma by the use of only CT findings. Pulmonary involvement of SS occurs in various forms so that SS patients with pulmonary involvement should undergo open biopsy to reach a definitive diagnosis.
Introduction
Sjögren's syndrome (SS) is a systemic autoimmune disease characterized by chronic inflammation of salivary and lacrimal glands with a variety of extra-glandular manifestations. The pulmonary incidence of SS was reported at 9-50% (1-3). Patients with SS may develop interstitial lung disease such as non-specific interstitial pneumonia (NSIP), usual interstitial pneumonia (UIP), lymphocytic interstitial pneumonia (LIP), and bronchiolitis (4) . In addition, they are at increased risk of developing low-grade lymphomas such as mucosa-associated lymphoid tissue (MALT) lymphoma (5) (6) (7) .
The high-resolution CT appearance of LIP is characterized by ground-glass opacities, poorly defined centrilobular nodules, and cystic airspaces (4-7). However, we had a patient with SS showing these typical CT findings of LIP but in whom pulmonary MALT lymphoma was confirmed by pathological examination of biopsied tissue. It is likely that some cases previously reported with radiologic 'LIP pattern' could have also included lymphomas (4).
Case Report
A 49-year-old woman with a 20-year history of SS was incidentally found to have an abnormal shadow on chest Xray along with de-saturation (Fig. 1) . She had dyspnea on effort and sicca symptoms like dry eye and dry mouth. Her laboratory data, revealed antinuclear antibody in a speckled pattern with 1,280 titers. Her SS-A/Ro antibody and SS-B/ La antibody were positive. Her sIL2-R, KL-6 and SP-D were respectively 1,130 U/mL, 2,053 U/mL and 206.0 ng/ mL ( Table 1 ). The CT findings showed traction bronchiecta- sis, multiple cystic changes, ground-glass opacity, and small nodules in all lung fields (Fig. 2a, b ). These CT findings are compatible with the 'LIP pattern' that has been reported previously (1, 2) . Therefore, to arrive at a definitive diagnosis she underwent video-assisted thoracic surgery (VATS) from S 2 of the right upper lobe as a normal control site and S 4 of the middle lobe as an abnormal site. Specimens from a part of the middle lobe revealed peri-bronchocentric diffuse lymphocytic infiltration with lympho-epithelial lesions and Dutcher bodies (Fig. 3a, 4a, b) . Immunohistochemically, the lymphocytic cells showed kappa Ig light chain restriction and CD20 positivity (Fig. 3b, c) . Furthermore, microscopic findings in her background lung tissue showed chronic inflammatory changes that were not diagnostic of interstitial pneumonias such as LIP or NSIP. Finally, the diagnosis was decided to be MALT lymphoma, based on chronic inflammatory lung changes due to SS. The range of invasion of her lymphoma was unknown, and no evidence of neoplastic infiltration was detected in bone marrow. However, we categorized her Ann Arbor staging of MALT lymphoma as stage 4 from pathological findings based on diffuse lung infiltration by MALT lymphoma.
She received Rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) chemotherapy for Stage 4a according to the Ann-Arbor classification. After this chemotherapy, her symptoms (except sicca) were resolved and her CT findings were markedly improved (Fig. 2c, d ). In addition, her inflammatory markers also decreased, for example sIL2-R 385 U/mL, KL-6 329 U/mL, and SP-D 47.4 ng/mL. 
Discussion
We report a case of a pulmonary localization of MALT lymphoma associated with SS presenting with multiple cystic lesions on the CT scan. SS is a common rheumatologic disorder characterized by the degeneration of exocrine glands. The frequency of lung diseases like interstitial pneumonia in SS ranges widely from 9 to 50 % (1-3). NonHodgkin's lymphoma develops in approximately 5% of SS patients (8) (9) (10) . In the majority of patients, the histopathologic type of lymphoma is MALT lymphoma. The origin of NHL is extranodal in approximately 80-85% of SS patients; with the salivary gland being the most frequent site (11) . MALT lymphoma in the lung is reported to evolve in 10-30% of the SS patients (12) (13) (14) .
The chest CT findings of SS patients in three different studies included areas of ground-glass opacity (14-92%), subpleural small nodules (38-78%), nonseptal linear opacity (16-75%), bronchiectasis (4-38%), cysts (27-30%), and air space consolidation (6-25%) (5-7). High-resolution CT findings in LIP are characterized by the presence of groundglass opacity, poorly defined centrilobular nodules, and interlobular septal thickning. We defined them as 'LIP pattern' in CT. In addition, SS patients with LIP frequently have cystic airspaces (68%) (15, 16) .
On the other hand, the major CT features of MALT lymphoma are characterized by the presence of bilateral, multifocal nodules and airspace consolidation with or without airbronchograms (17) . The chest CT findings in the present case were compatible with the 'LIP pattern' in CT.
However, two recent reports (4, 18) on pathological findings using criteria from the American Thoracic Society/ European Respiratory Society classification (19) explained that most major histological patterns of lung disease found on biopsy were nonspecific interstitial pneumonia (NSIP), and that lymphocytic interstitial pneumonia (LIP) was very rare. That is to say, many CT findings of lung disease complicated with SS such as LIP in CT are based on the past reports (5) (6) (7) 16 ).
In the above two reports (4, 18), 6 of 51 patients of SS had malignant lymphoma and 3 cases of the 51 had LIP. Furthermore, multifocal cysts were seen in six of 51 patients (two with LIP, two with malignant lymphoma, two with amyloidosis). Some authors have proposed that the formation of bronchioectasis and cystic changes might be due to air-trapping occurring as the result of chronic bronchial inflammation and increased epithelial airway damage by inflammatory cells (20, 21) . We suggest that some SS patients with multiple cysts in chest CT were complicated with LIP, malignant lymphoma, and amyloidosis (4, 18) .
The final diagnosis that we reached for the present case by VATS was MALT lymphoma. Her symptoms (except for sicca syndrome) improved dramatically in a week after the 3rd course of R-CHOP therapy. Concerning CT findings (Fig. 2c, d) , the cyst wall thickness, nodules and ground glass opacity improved, and only the cysts remained after treatment. It is very likely that some of the radiological findings without cysts might show MALT lymphoma. It is difficult to describe the radiological-pathological correlation in detail.
In conclusion, we report a case of a pulmonary localization of MALT lymphoma associated with SS presenting with LIP pattern and cystic features on chest CT scan. We emphasize that cystic changes of SS patients on CT were specific in SS patients, but not in LIP. The present case illustrates the fact that the presence of an associated tumor must be considered in the differential diagnosis of LIP pattern in CT, and this may justify additional surgical biopsy for diagnosis and staging. We recommend VATS in SS, when suspecting, to diagnose co-existing lymphoma since dramatic responses to chemotherapy can be expected.
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